| Literature DB >> 27384505 |
Stephan Kellnberger1,2, Walter Assmann3, Sebastian Lehrack3, Sabine Reinhardt3, Peter Thirolf3, Daniel Queirós1, George Sergiadis4, Günther Dollinger5, Katia Parodi3, Vasilis Ntziachristos1.
Abstract
Ions provide a more advantageous dose distribution than photons for external beam radiotherapy, due to their so-called inverse depth dose deposition and, in particular a characteristic dose maximum at their end-of-range (Bragg peak). The favorable physical interaction properties enable selective treatment of tumors while sparing surrounding healthy tissue, but optimal clinical use requires accurate monitoring of Bragg peak positioning inside tissue. We introduce ionoacoustic tomography based on detection of ion induced ultrasound waves as a technique to provide feedback on the ion beam profile. We demonstrate for 20 MeV protons that ion range imaging is possible with submillimeter accuracy and can be combined with clinical ultrasound and optoacoustic tomography of similar precision. Our results indicate a simple and direct possibility to correlate, in-vivo and in real-time, the conventional ultrasound echo of the tumor region with ionoacoustic tomography. Combined with optoacoustic tomography it offers a well suited pre-clinical imaging system.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27384505 PMCID: PMC4935843 DOI: 10.1038/srep29305
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Experimental setup for 2D ionoacoustic imaging of proton beams.
(a) Schematic of the 2D raster scan system using a focused high resolution acoustic wave sensor to characterize the proton dose distribution in water. Increased energy losses could be induced by means of an aluminum absorber inserted into the beam path. (b) Maximum intensity projection after raster scanning the proton beam. Arrows mark the position of the maximum. (c) Line profile of the Bragg peak in x and y direction, showing the measurement points (triangle and squares) and Gaussian fits to calculate the full width half maximum (FWHM). In x-direction, we determined the FWHM to be 2.4 ± 0.3 mm (red line) and in y-direction 2.3 ± 0.3 mm (blue line). (d) Bragg beak characterization with Al absorber. Maximum intensity projection of the particle beam after introducing a 0.5 mm Al sheet in the beam axis immediately after the vacuum exit window, arrows mark the maximum of the Bragg peak. (e) Line profile of the Bragg peak in x and y direction, illustrating scanning points and Gaussian fits to determine the FWHM.
Figure 2Three-dimensional tomographic scan of the Bragg peak.
(a) Experimental setup for 3D ionoacoustic imaging. (b) Maximum intensity projection of the 3D reconstruction in the xy plane. The arrows indicate the position of the maximum in x and y axis. (c) Image of the reconstructed volume, showing the MIP in the yz-plane. The line profile depicts the position of the Bragg peak at a distance of 4.3 ± 0.2 mm from the polyimide foil and further reveals a longitudinal FWHM of the Bragg peak of 0.28 ± 0.05 mm. (d) Image of the Bragg peak after introducing an aluminum absorber in the beam path. The arrows indicate the position of the Bragg peak maximum. (e) Proton range determination using ionoacoustic tomography. The inserted aluminum absorber reduces the range of protons in water.
Figure 3Triple-modality imaging of a mouse leg using optoacoustics, ionoacoustics, and ultrasonography.
(a) Schematic of the opto- and ionoacoustic experiment. For ultrasonography we replaced the curved array with a linear US-array (picture not shown). (b) Optoacoustic reconstruction of a mouse leg positioned in the proton beam line (scale bar represents 2 mm, star marks the medial marginal vein). (c) Ultrasonography of the mouse leg, showing metatarsal bones (scale bar represents 2 mm). (d) Cryoslice of a mouse leg with the ionoacoustic reconstruction (magenta color) co-registered to the optical image, displaying the Bragg peak at the distal end of the leg with a proton range dz = 4.7 ± 0.2 mm (star marks the medial marginal vein).